Sanofi Genzyme

Sanofi Unites Under a Single Purpose at Cambridge Crossing
BioSpace
Mon, 03/14/22 - 10:29 am
Sanofi
headquarters
Cambridge
Sanofi Pasteur
Sanofi Genzyme
Sanofi Genzyme’s Bill Sibold Champions Diversity, Community Responsibility
BioSpace
Thu, 11/19/20 - 10:38 am
Sanofi Genzyme
Bill Sibold
diversity
Sanofi and Regeneron's medical congress campaign focuses on type 2 inflammation education for docs
Fierce Pharma
Tue, 11/19/19 - 11:36 pm
Sanofi Genzyme
Regeneron
Dupixent
inflammation
Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics
Endpoints
Mon, 06/17/19 - 11:26 pm
Sanofi Genzyme
Voyager Therapeutics
gene therapy
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
Sanofi Genzyme has its expansive sights set on a new tech campus in Cambridge — report
Endpoints
Mon, 10/15/18 - 10:34 am
Sanofi Genzyme
headquarters
Cambridge MA
Regulus lays off 60% of staff, halts development
Biopharma Dive
Fri, 07/6/18 - 12:18 pm
Regulus
layoffs
restructuring
RG-012
Sanofi Genzyme
Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years
CP Wire
Tue, 04/24/18 - 09:02 am
Sanofi Genzyme
Lemtrada
MS
Relapsing Remitting Multiple Sclerosis
Sanofi Genzyme announces 130 staff cuts
GoinPharma
Thu, 02/8/18 - 11:50 pm
Sanofi Genzyme
layoffs
drug manufacturing
Sanofi Genzyme issues recall for contaminated arthritis gel
Boston Globe, MA
Tue, 12/12/17 - 10:45 pm
Sanofi Genzyme
recalls
Sanofi Genzyme hit with patent lawsuit over new eczema drug
Bizjournals.com
Thu, 04/20/17 - 09:48 am
Sanofi Genzyme
patents
eczema
Dupixent
Immunex
Amgen
David Meeker, longtime head of Sanofi Genzyme, to leave company after 23 years
Bizjournals.com
Fri, 04/7/17 - 09:46 am
David Meeker
Sanofi Genzyme
Sanofi Genzyme head weighs in on drug price debate
Bizjournals.com
Fri, 02/3/17 - 11:20 am
Sanofi Genzyme
drug pricing
Sanofi releases strong 3rd quarter results
Fri, 10/28/16 - 12:09 pm
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
Bizjournals.com
Fri, 10/28/16 - 10:19 am
FDA
Sanofi
Sanofi Genzyme
drug manufacturing
biosimilars
Humira
Sarilumab
​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
Mon, 09/26/16 - 09:45 am
FDA
Sanofi Genzyme
Regeneron
Sarilumab
dupilumab
eczema
rheumatoid arthritis
Sanofi Genzyme Begins Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients with Acid Sphingomyelinase Deficiency
Yahoo
Wed, 07/6/16 - 09:49 am
Sanofi Genzyme
clinical trials
olipudase alfa
Niemann-Pick disease
Sanofi Genzyme to begin late-stage trial of new drug for Pompe disease by summer
Bizjournals.com
Fri, 03/4/16 - 02:21 pm
Sanofi Genzyme
Pompe disease
clinical trials
NeoGAA
​Sanofi Genzyme revenues grow 20% in 2015 to top $4B
Bizjournals.com
Tue, 02/9/16 - 09:06 am
Sanofi Genzyme
earnings